AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list
A Comprehensive Review on the Pharmacokinetics and Drug-Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist
Glutathione is a powerful antioxidant that consists of three amino acids: Cysteine, Glutamic Acid, & Glycine
Make sure youre getting adequate B2, magnesium, selenium, and vitamin C, either through diet or supplementation
BPC-157 exhibits systemic distribution, but regional administration increases peak tissue levels at the target site by 3050% based on rodent perfusion studies
This peptide was originally isolated from human gastric juice in 1993 by Dr
